Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Esomeprazole Combined With Sucralfate Suspension for Ulcer Healing and Complication Prevention After Gastric Endoscopic Submucosal Dissection: A Prospective, Randomized, Controlled Trial

NCT07312370 is registered in ClinicalTrials.gov with LanZhou University as lead sponsor.

NCT NCT07312370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07312370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Esomeprazole Combined With Sucralfate Suspension for Ulcer Healing and Complication Prevention After Gastric Endoscopic Submucosal Dissection: A Prospective, Randomized, Controlled Trial
Lead sponsor
LanZhou University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
April 20, 2026
Completion date
December 30, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early gastric cancer, gastric dysplasia, gastric neoplasms, gastric ulcer, peptic ulcer with haemorrhage